Lectures

Stomach Ulcer (Peptic Acid Disease) Medication

by Pravin Shukle, MD
(1)

Questions about the lecture
My Notes
  • Required.
Save Cancel
    Learning Material 2
    • PDF
      Slides Gastrointestinal Pharmacology.pdf
    • PDF
      Download Lecture Overview
    Report mistake
    Transcript

    About the Lecture

    The lecture Stomach Ulcer (Peptic Acid Disease) Medication by Pravin Shukle, MD is from the course Gastrointestinal Pharmacology.


    Included Quiz Questions

    1. Magnesium hydroxide --- laxative effect Aluminum hydroxide --- constipating effect Calcium carbonate --- absorbed by the gut
    2. Magnesium hydroxide --- constipating effect Aluminum hydroxide --- absorbed by the gut Calcium carbonate --- laxative effect
    3. Magnesium hydroxide --- constipating effect Aluminum hydroxide --- laxative effect Calcium carbonate --- constipating effect
    4. Magnesium hydroxide --- laxative effect Aluminum hydroxide --- absorbed by the gut Calcium carbonate --- constipating effect
    5. Magnesium hydroxide --- laxative effect Aluminum hydroxide --- constipating effect Calcium carbonate --- laxative effect
    1. Blocks histamine receptor type 2 in parietal cells.
    2. Blocks histamine receptor type 2 in the chief cells.
    3. Blocks histamine receptor type 1 in the surface mucous cells.
    4. Blocks hydrochloric acid production by the G cells.
    5. Blocks hydrochloric acid production by the gastric glands.
    1. Omeprazole enters the parietal cell with a neutral charge and becomes protonated.
    2. Omeprazole enters the parietal cell with a neutral charge and becomes polymerized.
    3. Omeprazole enters the parietal cell with a neutral charge and becomes hydroxylated.
    4. Omeprazole enters the parietal cell with a neutral charge and becomes hydrolyzed.
    5. Omeprazole enters the parietal cell with a positive charge and becomes activated when it binds with magnesium ions.
    1. Increased risk of enteric infection.
    2. Increased risk of sepsis.
    3. Increased risk of developing hirsutism.
    4. Increased risk of anxiety.
    5. Increased risk of developing dermatitis nigricans.
    1. Misoprostol is a prostaglandin E1 analog to increase gastric mucous production.
    2. Misoprostol is a prostaglandin E3 analog to increase gastric acid production.
    3. Misoprostol is a prostaglandin E2 analog to reduce gastric mucous production.
    4. Misoprostol is a neuraminidase analog to increase gastric antibody production.
    5. Misoprostol is a ghrelin analog to increase gastric acid production and reduce gastric mucous production.

    Author of lecture Stomach Ulcer (Peptic Acid Disease) Medication

     Pravin Shukle, MD

    Pravin Shukle, MD


    Customer reviews

    (1)
    5,0 of 5 stars
    5 Stars
    5
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1  Star
    0